Leveragen partners with Cell Signaling for Nanobody Technology
25 Mar 2025 //
BUSINESSWIRE
Leveragen, Moonlight Bio Partner On T Cell Therapies
29 Jan 2025 //
BUSINESSWIRE
Antibody Solutions Approved as CRO for Leveragen’s Singularity Mouse
14 Nov 2024 //
BUSINESSWIRE